Ion Torrent shows power of DNA sequencer based on computer chip tech; IDBS calling MA location U.S. base;

> MIT's Technology Review profiled Cambridge, MA-based biotech upstart Nimbus and the company's strategy to emphasize computational drug discovery with technology from its partner Schrödinger. Article

> An employee of lab software provider Accelrys ($ACCL) has something to say about in-silico techniques to increase the productivity of drug R&D. Column

> Zacks reports that shares of Medidata Solutions ($MDSO) might be a good buy ahead of the clinical trials software company's earnings release next month. Item

> Here's an analysis of Ion Torrent's DNA sequencing machine that is based on semiconductor chip technology. Report

> IDBS, a U.K.-based provider of electronic laboratory notebook software, plans to make its Burlington, MA, office its U.S. headquarters and expand its staff at the location. Report

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.